ArticleJournal of Cancer2020

Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus Capecitabine.

Fang L I Ang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.